Systemic Bio Opens Bioprinting Lab to Accelerate Drug Discovery

3D Systems (NYSE: DDD) spinoff Systemic Bio opened a state-of-the-art laboratory to conduct research into hydrogel scaffold manufacturing and organ-on-a-chip as part of its mission to accelerate drug discovery and…


3D Systems Spins off Bioprinting Startup Systemic Bio

After venturing deeply into the bioprinting space, 3D Systems (NYSE: DDD) is shifting gears by spinning out its assets in this sector into a new, wholly owned company: Systemic Bio….